Pepceuticals Ltd
03533670
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 06/09/2025
Due 20/09/2026
Industry
Officers
director · Since 10/11/2025
CEO
AMERICAN · UNITED STATES · Age 46
Also on 6 other boards
Persons with Significant Control
Biosynth Group Limited
Axis House, High Street, Newbury, RG20 6NL
Reg: 13690981 · England · Private Company Limited By Shares
Notified 21/09/2023
Former PSCs
Dr Kamal Badiani
Ceased 21/08/2023
Charges0 outstanding
BARCLAYS BANK PLC
CompanyRankvs 105+ SIC 20140 peers88
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£14.3M
Balance sheet strength
Cash
£131k
Cash in the bank
Net Current Assets
£13.2M
Working capital
Current Assets
£13.7M
Current Liabilities
£467k
Fixed Assets
£1.2M
Debtors
£13.6M
Tax at Year End(2019)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 29.31 | +£1.1M |
| 2023 | 46.66 | +£638k |
| 2023 | 27.50 | +£1.1M |
| 2022 | 18.54 | +£2.5M |
| 2021 | 13.04 | +£1.3M |
| 2020 | 515.29 | +£998k |
| 2019 | 27.74 | — |
Derived from filed accounts. Not audited figures.